acarix English, Interim, IR, Listing Regulation, News, Q2, Regulatory, Report November 18, 2024 31 Aug 2023 Acarix AB (publ) publishes Interim Report, April – June 2023 Traction in the US market reflects transition to a new expanded commercial modelIn 2022, we initiated the transition of Acarix to full ... Continue reading
acarix Interim, IR, Listing Regulation, News, Q2, Regulatory, Report, Swedish November 18, 2024 31 Aug 2023 Acarix AB (publ) publicerar delårsrapport, april – juni 2023 Dragkraft på den amerikanska marknaden återspeglar övergången till en ny kommersiell modellUnder 2022 påb&... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 30 Aug 2023 Invitation to presentation of Acarix´s second quarter earnings report Acarix, a leader in acoustic and AI-based cardiac diagnostics, will publish its second quarter results on Thursday 31 August 2023 08:00... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 30 Aug 2023 Inbjudan till presentation av Acarix rapport för andra kvartalet Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, publicerar resultatet för andra kvartalet torsdagen den 31 augu... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 29 Aug 2023 First Veterans Affairs Healthcare System Standardizes Use of Acarix CADScor System Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces a significant advancement in the utilization of its CADS... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 29 Aug 2023 Första sjukhuset inom Veterans Affairs Healthcare System standardiserar användningen av Acarix CADScor System Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, tillkännager idag ett betydande framsteg i användningen av... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 28 Aug 2023 Acarix welcomes Dr. Deepak R. Talreja MD as new Medical Advisor Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today the appointment of Dr. Deepak R. Talreja, MD, as new Med... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 28 Aug 2023 Acarix välkomnar Dr. Deepak R. Talreja MD som ny medicinsk rådgivare Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, tillkännager idag utnämningen av Dr. Deepak R. Talreja, MD... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 23 Aug 2023 Acarix to participate in Erik Penser Bank’s Company Day on August 24, 2023 Acarix, a leader in acoustic and AI-based cardiac diagnostics, is pleased to announce participation in the upcoming Erik Penser Bank Co... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 23 Aug 2023 Acarix deltar på Erik Penser Banks Bolagsdag den 24 augusti 2023 Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, meddelar sitt deltagande i den kommande Erik Penser Banks Bolagsdag ... Continue reading
acarix Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM November 18, 2024 09 Jun 2023 Announcement from Acarix’s extra general meeting The extra general meeting of Acarix AB (the "Company") was held today on 9 June 2023 and the following resolutions were passed by the m... Continue reading
acarix Corporate Information, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM, Swedish November 18, 2024 09 Jun 2023 Kommuniké från extra bolagsstämma i Acarix Extra bolagsstämma i Acarix AB ("Bolaget") hölls idag den 9 juni 2023 varvid aktieägarna fattade följande beslut.Be... Continue reading